Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Xeomin (Botulinum neurotoxin type A) for lower limb and/or upper limb spasticity	Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607)	Lower limb spasticity , Upper limb spasticity	Musculoskeletal System	2023	View \| Download
Zanidatamab for treating advanced or metastatic HER2-positive biliary tract cancer in adults	Zanidatamab (ZW-25)	Biliary tract cancer	Gastrointestinal Cancer	2023	View \| Download
Zanubrutinib for previously treated mantle cell lymphoma	Zanubrutinib (BGB-3111; Brukinsa)	Mantle cell lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Zanubrutinib plus obinutuzumab for treating relapsed or refractory follicular lymphoma	Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) , Zanubrutinib (BGB-3111; Brukinsa)	Follicular lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Zuranolone for treating moderate to severe postpartum depression	Zuranolone	Postpartum depression	Mental and Behavioural Health	2023	View \| Download